Scientists from UC San Francisco and Oregon Health & Science University (OHSU) have teamed up to tackle acute lymphoblastic leukemia (ALL), a blood cancer that typically affects children from two to five years old.Read More
Science Market Update
Tags: CA, Leukemia, Oregon Health and Science University, cancer research, Oregon, California, Pediatric Cancer Research, 2015, San Francisco, SFVS, BioResearch Product Faire Event, OR, UCSF, OHSU, Portland, UC San Francisco, Biotechnology Vendor Showcase Event
Already the nation’s leading university for medical research, UCSF continues to expand thanks to a generous and recent donation.Read More
The UC San Francisco Medical Center is home to some of nation’s best doctors, industry-leading bio-researchers, and most recently, an angel. UCSF is proudly unveiling a new outpatient medical building- thanks to a $40 million gift from “angel investor” and philanthropist Ron Conway and his family.Read More
One of the most baffling and crippling sorts of diseases are those that incite the immune system to attack the body. This class of diseases, known as autoimmune diseases, may seem like a very specialized and rare affliction, but in truth, it manifests itself in the form of several commonly known ailments like rheumatoid arthritis, asthma, type 1 diabetes, and multiple sclerosis. A new study from the University of California, San Francisco points to some of the causes and thus possible treatments for autoimmune diseases.Read More
There are thousands of genes in the human genome that all have different purposes. At least 3,000 of these genes are known to express proteins that can be altered by different medications, however, the FDA has only approved drugs that target around 10 percent of these genes. That means that there are still thousands of genes that have not been thoroughly studied that, with the help of the right medication, could be targeted to help improve human health. The National Institutes of Health Common Fund has awarded 8 U.S. institutions $5.8 million for a new collaborative three-year program called Illuminating the Druggable Genome (IDG) that will study different genes and their potential to be modified by different medicines.Read More
Tags: CA, Mount Sinai School of Medicine, University of California San Francisco, Texas Medical Center, New York, Southwest, 2015, MSSM, tmc, San Francisco, SFVS, BioResearch Product Faire Event, Houston, NY, TX, UC San Francisco, Biotechnology Vendor Showcase Event, North East
The three-year grant will enable a group of UCSF researchers to continue their development of the SMART diaphragm, a wireless device that can detect preterm labor onset sooner and more easily than current methods.
Researchers interested in meeting other researchers and learning about the latest life science solutions on the market are invited to attend Biotechnology Calendar, Inc.’s University of California, San Francisco life science event on February 6th, 2014. Last year, the San Francisco, Mission Bay Biotechnology Vendor Showcase™ Event attracted 280 attendees. This is the perfect opportunity to connect with colleagues in other departments and sales representatives interested in hearing about your work’s successes and your problems in the lab.
Tags: California, CA, Southwest, University of California San Francisco, San Francisco, Mission Bay, 2013, 2014, meet researchers, researcher invite, University of California San Francisco Mission Bay, SFVS, Biotechnology Vendor Showcase
The California Institute for Quantitative Biosciences recently opened a new bioscience incubator close to the University of California San Francisco campus at Mission Bay. The Institute is commonly referred to as QB3 and is affiliated with UC Berkeley, UC Santa Cruz and UC San Francisco.
Tags: UCSF, California, Southwest, University of California San Francisco, San Francisco, QB3, Mission Bay, 2014, Bioscience, University of California San Francisco Mission Bay, SFVS, Biotechnology Vendor Showcase
The University of California, San Francisco was recently ranked number two in the country for receiving biomedical research grants from the NIH, and it was also the number one ranked public school in the country for receiving these grants. According to the University of California, San Francisco news page, this funding allows UCSF researchers to undertake groundbreaking studies that aim at a better understanding of cancer, diabetes, HIV, Parkinson’s, Alzheimer’s and cardiovascular disease.
Tags: UCSF, California, CA, Southwest, University of California San Francisco, San Francisco, Parnassus, 2013, UC San Francisco, 2014, SFVS, University of California San Francisco Parnassus, Biotechnology Vendor Showcase